IP Library Granted Patent US 11,400,071
Granted Patent B2
US 11,400,071 · App. 16/909,128 · Granted Aug 2, 2022

Hest G-18-0 and benzoyl peroxide compositions and methods for using the same

Inventors: Kathy Ann Fields (San Francisco, CA); Kathryn Pregerson Rodan (Oakland, CA); George Paul Majewski (Walnut, CA); Timothy John Falla (Woodinville, WA); Dzung Q. Le (Salt Lake City, UT)
Assignee: Rodan & Fields, LLC
A61K31/327A61K9/0014A61K9/08A61K31/08A61K31/19A61K47/10A61K47/12A61J1/2093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,400,071
App. No.
16/909,128
Granted
Aug 2, 2022
Kind
B2
Abstract

The compositions of the various embodiments include benzoyl peroxide and Hest G-18-0. The methods of this invention include treating acne, increasing the solubility of benzoyl peroxide, and treating the skin. Embodiments are also directed to a dual chamber package comprising a chamber for benzoyl peroxide and a chamber for Hest G-18-0.

Claims (36)

1. A topical composition comprising:

a first composition containing about 5% by weight of benzoyl peroxide and a cosmetically acceptable excipient, and does not contain adapalene, and

a second composition containing about 15% Hest G-18-0 and a cosmetically acceptable excipient,

wherein the first composition and the second composition are combined before use to form the topical composition and wherein the benzoyl peroxide is solubilized in the Hest G-18-0.

2. The topical composition of claim 1 , wherein the cosmetically acceptable excipient of the first composition is selected from the group consisting of polysaccharide polymer, glycerin, butylene glycol, acrylamide/sodium acryloyodimethyltaurate copolymer, isohexadecane, phenoxyethanol, polysorbate 80, ethylhexylglycerin, sodium hydroxide, dipropylene glycol, pentylene glycol, polyethylene glycol, ethanol, water, and combinations thereof.

3. The topical composition of claim 1 , wherein the first composition further comprises an effective amount of tocopherol.

4. The topical composition of claim 1 , wherein the cosmetically acceptable excipient of the second composition is selected from the group consisting of polysaccharide polymer, glycerin, butylene glycol, propanediol, dimethyl isosorbide, acrylamide/sodium acryloyodimethyltaurate copolymer, propylene glycol, phenoxyethanol, isohexadecane, methyl methacrylate crosspolymer, polysorbate 80, ethylhexylglycerin, 1,2-hexanediol, cetyl hydroxyethylcellulose, dipropylene glycol, pentylene glycol, polyethylene glycol, ethanol, water, and combinations thereof.

5. The topical composition of claim 1 , wherein the second composition further comprises an effective amount of Vaccinium angustifolium (Blueberry) fruit extract.

6. The topical composition of claim 1 , wherein the benzoyl peroxide is at a concentration of about 2.5% by weight of the topical composition upon combination of the first composition and the second composition.

7. The topical composition of claim 1 , wherein the Hest G-18-0 is at a concentration of about 7.5% by weight of a topical composition upon combination of the first composition and the second composition.

8. A method of treating acne comprising applying to a subject's skin a topical composition comprising:

a first composition containing about 5% by weight of benzoyl peroxide and a cosmetically acceptable excipient, and does not contain adapalene, and

a second composition containing about 15% Hest G-18-0 and a cosmetically acceptable excipient,

wherein the first composition and the second composition are combined before use to form the topical composition and wherein the benzoyl peroxide is solubilized in the Hest G-18-0.

9. The method of claim 8 , wherein the composition reduces skin erythema, skin irritation, drying of the skin, cracking of the skin, and appearance of white residue on the skin.

10. The method of claim 8 , wherein subject compliance is increased.

11. The method of claim 8 , wherein the benzoyl peroxide efficacy is increased as part of the topical composition.

12. The method of claim 8 , wherein the cosmetically acceptable excipient of the first composition is selected from the group consisting of polysaccharide polymer, glycerin, butylene glycol, acrylamide/sodium acryloyodimethyltaurate copolymer, isohexadecane, phenoxyethanol, polysorbate 80, ethylhexylglycerin, sodium hydroxide, dipropylene glycol, pentylene glycol, polyethylene glycol, ethanol, water, and combinations thereof.

13. The method of claim 8 , wherein the first composition further comprises an effective amount of tocopherol.

14. The topical composition of claim 8 , wherein the cosmetically acceptable excipient of the second composition is selected from the group consisting of polysaccharide polymer, glycerin, butylene glycol, propanediol, dimethyl isosorbide, acrylamide/sodium acryloyodimethyltaurate copolymer, propylene glycol, phenoxyethanol, isohexadecane, methyl methacrylate crosspolymer, polysorbate 80, ethylhexylglycerin, 1,2-hexanediol, cetyl hydroxyethylcellulose, dipropylene glycol, pentylene glycol, polyethylene glycol, ethanol, water, and combinations thereof.

15. The method of claim 8 , wherein the second composition further comprises an effective amount of Vaccinium angustifolium (Blueberry) fruit extract.

16. The method of claim 8 , wherein the benzoyl peroxide is at a concentration of about 2.5% by weight of the topical composition upon combination of the first composition and the second composition.

17. The method of claim 8 , wherein the Hest G-18-0 is at a concentration of about 7.5% by weight of a topical composition upon combination of the first composition and the second composition.

18. A dual chamber package comprising:

a first chamber containing a first composition containing about 5% by weight of benzoyl peroxide and a cosmetically acceptable excipient, and does not contain adapalene; and

a second chamber containing a second composition containing about 15% by weight of Hest G-18-0 and a cosmetically acceptable excipient,

wherein the first composition and the second composition are combined before application to a subject's skin to form a topical composition and wherein the benzoyl peroxide is solubilized in the Hest G-18-0.

19. The package of claim 18 , wherein the topical composition is applied to the skin of a subject and reduces skin erythema, skin irritation, drying of the skin, cracking of the skin, and appearance of white residue on the skin.

20. The package of claim 19 , wherein the subject's use and compliance of the topical composition is increased.

21. The package of claim 18 , wherein the benzoyl peroxide efficacy is increased as part of the topical composition.

22. The package of claim 18 , wherein the cosmetically acceptable excipient of the first composition is selected from the group consisting of polysaccharide polymer, glycerin, butylene glycol, acrylamide/sodium acryloyodimethyltaurate copolymer, isohexadecane, phenoxyethanol, polysorbate 80, ethylhexylglycerin, sodium hydroxide, dipropylene glycol, pentylene glycol, polyethylene glycol, ethanol, water, and combinations thereof.

23. The package of claim 18 , wherein the first composition further comprises an effective amount of tocopherol.

24. The package of claim 18 , wherein the cosmetically acceptable excipient of the second composition is selected from the group consisting of polysaccharide polymer, glycerin, butylene glycol, propanediol, dimethyl isosorbide, acrylamide/sodium acryloyodimethyltaurate copolymer, propylene glycol, phenoxyethanol, isohexadecane, methyl methacrylate crosspolymer, polysorbate 80, ethylhexylglycerin, 1,2-hexanediol, cetyl hydroxyethylcellulose, dipropylene glycol, pentylene glycol, polyethylene glycol, ethanol, water, and combinations thereof.

25. The package of claim 18 , wherein the second composition further comprises an effective amount of Vaccinium angustifolium (Blueberry) fruit extract.

26. The package of claim 18 , wherein the benzoyl peroxide is at a concentration of about 2.5% by weight of the topical composition upon combination of the first composition and the second composition.

27. The package of claim 18 , wherein the Hest G-18-0 is at a concentration of about 7.5% by weight of a topical composition upon combination of the first composition and the second composition.

Assignments (14)
ASSIGNMENT OF SECURITY INTERESTS IN PATENT COLLATERAL Recorded Feb 2, 2026
From: CITIBANK, N.A., IN ITS CAPACITY AS THE WITHDRAWING AGENT
To: ANKURA TRUST COMPANY, LLC, IN ITS CAPACITY AS SUCCESSOR AGENT
Reel/Frame 074643/0097 →
MERGER Recorded Oct 9, 2024
From: RODAN & FIELDS, LLC
To: RODAN & FIELDS BEAUTY, LLC
Reel/Frame 068844/0351 →
PATENT SECURITY AGREEMENT Recorded Sep 27, 2024
From: RODAN & FIELDS BEAUTY, LLC
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
Reel/Frame 069066/0818 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON APRIL 28, 2023, AT REEL/FRAME 063480/0786 Recorded Sep 27, 2024
From: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
To: RODAN & FIELDS, LLC
Reel/Frame 069066/0803 →
PATENT SECURITY AGREEMENT Recorded Sep 27, 2024
From: RODAN & FIELDS BEAUTY, LLC
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
Reel/Frame 069066/0810 →
SECURITY INTEREST Recorded May 2, 2023
From: RODAN & FIELDS, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 063501/0804 →
SECURITY INTEREST Recorded May 2, 2023
From: RODAN & FIELDS, LLC
To: CITIBANK, N.A.
Reel/Frame 063501/0785 →
SECURITY INTEREST Recorded Apr 28, 2023
From: RODAN & FIELDS, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 063480/0786 →
SECURITY INTEREST Recorded Apr 28, 2023
From: RODAN & FIELDS, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 063480/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2020
From: RODAN, KATHRYN PREGERSON
To: RODAN & FIELDS, LLC
Reel/Frame 053088/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2020
From: MAJEWSKI, GEORGE PAUL
To: RODAN & FIELDS, LLC
Reel/Frame 053088/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2020
From: FALLA, TIMOTHY JOHN
To: RODAN & FIELDS, LLC
Reel/Frame 053088/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2020
From: LE, DZUNG Q.
To: RODAN & FIELDS, LLC
Reel/Frame 053088/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2020
From: FIELDS, KATHY ANN
To: RODAN & FIELDS, LLC
Reel/Frame 053087/0975 →
Continuity (3)
Continuation 15616601 · Jun 7, 2017
Provisional Application 62346911 · Jun 7, 2016
Related Publication 20200338037A1 · Oct 29, 2020